Eiichi Makino

670 citations
28 papers · 420 indexed · h-index 10
Topics
S100 Proteins and Annexins (4 papers)Synthesis and Characterization of Heterocyclic Compounds (3 papers)Synthesis and biological activity (3 papers)

In The Last Decade

Eiichi Makino

26 papers receiving 418 citations

Peers

Eiichi Makino
Comparison fields: 5 of 81
  • Molecular Biology 238
  • Cancer Research 101
  • Oncology 61
  • Cell Biology 52
  • Dermatology 49
Replace Takenori Fujii with:
Takenori Fujii Japan
Chi‐Wei Lin United States
Petra Laspe Germany
Andrew P. Seddon United States
Lubna Qamar United States
Xinfeng Yan China
Janet Haasjes Netherlands
Daniela Di Marcantonio United States
Lata Singh India
Hideaki Iwaki Japan
Eiichi Makino relative to Takenori Fujii Japan Takenori Fujii's profile →
Citations per field
00.5×4.1×
Takenori Fujii · 1×
Citations per year

Countries citing papers authored by Eiichi Makino

Since Specialization
Citations

This map shows the geographic impact of Eiichi Makino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Makino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Makino more than expected).

Fields of papers citing papers by Eiichi Makino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiichi Makino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Makino. The network helps show where Eiichi Makino may publish in the future.

Co-authorship network of co-authors of Eiichi Makino

This figure shows the co-authorship network connecting the top 25 collaborators of Eiichi Makino. A scholar is included among the top collaborators of Eiichi Makino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiichi Makino. Eiichi Makino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 9
4 6
5 10
6 99
7 4
8 1
9 2
10 11
11 2
12 13
13 29
14 18
15 3
16 4
17 17
18 8
19 2
20 23

About Eiichi Makino

Eiichi Makino is a scholar working on Dermatology, Oncology and Toxicology, having authored 28 papers that have together received 420 indexed citations. Recurring topics across this work include S100 Proteins and Annexins (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers) and Synthesis and biological activity (3 papers). The work is most often cited by research in Cancer Research (101 citations), Dermatology (49 citations) and Clinical Biochemistry (26 citations). Eiichi Makino has collaborated with scholars based in Japan, United Kingdom and France. Frequent co-authors include Masakiyo Sakaguchi, Nam-ho Huh, Masayoshi Namba, Noriyuki Kataoka, Yoshihiko Sakaguchi, Hidenori Yamada, Wataru Fujimoto, Mikiro Takaishi, Masahiro Miyazaki and Keiji Iwatsuki. Their work appears in journals such as Cell, The Journal of Cell Biology and Journal of the American Academy of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026